Topic Editors
Advances in High Grade Glioma Research
Topic Information
Dear Colleagues,
High-grade gliomas (HGGs), particularly glioblastoma, are among the most aggressive and lethal tumors of the central nervous system, challenging even advanced diagnostic and prognostic strategies.
These tumors grow masked behind a plethora of neurological signs, having systemic effects. Surgery is restricted to the neuroanatomical location, while the blood–brain barrier limits drug treatments. HGGs appear with distinct biological features, establishing a structural relationship within the nervous tissue. The immune distribution is diverse between samples and correlates with tumor cell phenotype in a spatial orientation.
Despite advances in personalized medicine, spatial biology, immunotherapy, and a high-precision ion beam approach, patient prognosis remains unfavorable, requiring urgent studies to understand brain tumor biology, polarization of the microenvironment, and systemic mechanisms.
The combination of diverse treatments and technologies holds promise for improving the prognosis of HGG. The present topic aims to collect ideas, hypotheses, and proofs to leverage the knowledge provided by multitargeted approaches, such as immune checkpoint inhibitors, vaccines, or CAR-T cells, combined with nanomedicine, tumor treating fields (TTFields), artificial intelligence, or radiomics inter-field.
Therefore, journal articles, reviews, letters, and communications related to the aforementioned topics are welcome.
Dr. Assunta Virtuoso
Dr. Agata Grazia D'Amico
Dr. Celeste Caruso Bavisotto
Topic Editors
Keywords
- brain tumors
- human
- mammals
- astrocytes
- microglia
- oligodendroglia
- neuroanatomy
- neuropeptides
- imaging
Participating Journals
| Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
|---|---|---|---|---|---|---|
Brain Sciences
|
2.8 | 5.6 | 2011 | 15.6 Days | CHF 2200 | Submit |
Neurology International
|
3.0 | 4.8 | 2009 | 26.5 Days | CHF 1600 | Submit |
NeuroSci
|
2.0 | - | 2020 | 19.9 Days | CHF 1000 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
